When the phosphorylation of AKT was disturbed, the effect of CBX2 on glioma proliferation and chemoresistance was abolished, suggesting that CBX2 promotes glioma progression and chemoresistance through PTEN-controlled AKT activation. The gene discussed is PTEN; the disease is central nervous system cancer.